1.
Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases
by Kovacs, Gabor G
Journal of neuropathology and experimental neurology, 2017, Vol.76 (4), p.270-288

2.
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database
by Ringman, John M
Journal of neuropathology and experimental neurology, 2016, Vol.75 (3), p.284-290

3.
Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies
by Colom-Cadena, Martí
Journal of neuropathology and experimental neurology, 2013, Vol.72 (12), p.1203-1212

4.
Oxidative Damage Is the Earliest Event in Alzheimer Disease
by NUNOMURA, AKIHIKO
Journal of neuropathology and experimental neurology, 2001, Vol.60 (8), p.759-767

5.
Decreased Expression and Activity of Neprilysin in Alzheimer Disease Are Associated With Cerebral Amyloid Angiopathy
by Miners, James Scott
Journal of neuropathology and experimental neurology, 2006, Vol.65 (10), p.1012-1021

6.
Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease
by Yang, Yue
Journal of neuropathology and experimental neurology, 2015, Vol.74 (7), p.672-687

7.
Apolipoprotein E, Amyloid-β, and Blood-Brain Barrier Permeability in Alzheimer Disease
by Donahue, John E
Journal of neuropathology and experimental neurology, 2008, Vol.67 (4), p.261-270

8.
Lewy Body-Related α-Synucleinopathy in Aging
by SAITO, YUKO
Journal of neuropathology and experimental neurology, 2004, Vol.63 (7), p.742-749

9.
Neuropathology of Cognitively Normal Elderly
by KNOPMAN, D S
Journal of neuropathology and experimental neurology, 2003, Vol.62 (11), p.1087-1095

10.
Staging of Argyrophilic Grains: An Age-Associated Tauopathy
by SAITO, YUKO
Journal of neuropathology and experimental neurology, 2004, Vol.63 (9), p.911-918

11.
Apolipoprotein E and Alzheimer Disease: An Update on Genetic and Functional Analyses
by SAUNDERS, ANN M
Journal of neuropathology and experimental neurology, 2000, Vol.59 (9), p.751-758

12.
Alzheimer Disease Pathology in Subjects Without Dementia in 2 Studies of Aging: The Nun Study and the Adult Changes in Thought Study
by SantaCruz, Karen S
Journal of neuropathology and experimental neurology, 2011, Vol.70 (10), p.832-840

13.
Two Types of Sporadic Cerebral Amyloid Angiopathy
by THAL, DIETMAR RUDOLF
Journal of neuropathology and experimental neurology, 2002, Vol.61 (3), p.282-293

14.
Dietary Cholesterol and Its Effect on Tau Protein: A Study in Apolipoprotein E-Deficient and P301L Human Tau Mice
by Glöckner, Frauke
Journal of neuropathology and experimental neurology, 2011, Vol.70 (4), p.292-301

15.
Stable Size Distribution of Amyloid Plaques Over the Course of Alzheimer Disease
by Serrano-Pozo, Alberto
Journal of neuropathology and experimental neurology, 2012, Vol.71 (8), p.694-701

16.
Recent Advances in Neurotrauma
by GRAHAM, D I
Journal of neuropathology and experimental neurology, 2000, Vol.59 (8), p.641-651

17.
Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias
by MOTT, Ryan T
Journal of neuropathology and experimental neurology, 2005, Vol.64 (5), p.420-428

18.
Alzheimer Neuropathologic Alterations in Aged Cognitively Normal Subjects
by Davis, D G
Journal of neuropathology and experimental neurology, 1999, Vol.58 (4), p.376-388

19.
Aberrant Phosphorylation of α-Synuclein in Human Niemann-Pick Type C1 Disease
by SAITO, YUKO
Journal of neuropathology and experimental neurology, 2004, Vol.63 (4), p.323-328

20.
Distribution of Reducible 4-Hydroxynonenal Adduct Immunoreactivity in Alzheimer Disease is Associated with APOE Genotype
by Montine, Kathleen S
Journal of neuropathology and experimental neurology, 1998, Vol.57 (5), p.415-425
